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Abstract
Improved methods for the detection and characterization of carried Neisseria meningitidis
isolates are needed. We evaluated a multiplex PCR algorithm for the detection of a variety
of carriage strains in the meningitis belt. To further improve the sensitivity and specificity of
the existing PCR assays, primers for gel-based PCR assays (sodC, H, Z) and primers/
probe for real-time quantitative PCR (qPCR) assays (porA, cnl, sodC, H, E, Z) were modified
or created using Primer Express software. Optimized multiplex PCR assays were tested on
247 well-characterised carriage isolates from six countries of the African meningitis belt.
The PCR algorithm developed enabled the detection of N. meningitidis species using gel-
based and real-time multiplex PCR targeting porA, sodC, cnl and characterization of cap-
sule genes through sequential multiplex PCR assays for genogroups (A, W, X, then B, C, Y
and finally H, E and Z). Targeting both porA and sodC genes together allowed the detection
of meningococci with a sensitivity of 96% and 89% and a specificity of 78% and 67%, for
qPCR and gel-based PCR respectively. The sensitivity and specificity ranges for capsular
genogrouping of N. meningitidis are 67% - 100% and 98%-100% respectively for gel-based
PCR and 90%-100% and 99%-100% for qPCR. We developed a PCR algorithm that allows
simple, rapid and systematic detection and characterisation of most major and minor N.
meningitidis capsular groups, including uncommon capsular groups (H, E, Z).
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Introduction
Neisseria meningitidis has been responsible for numerous outbreaks of septicaemia and menin-
gitis in countries of the African Sahel and sub-Sahel, a region known as the “African meningi-
tis belt”[1]. The devastating nature of this disease, which predominately affects children and
young adults, makes its control an international health priority. N. meningitidis is a common
commensal bacterium capable of harmlessly colonizing the upper respiratory tract in a
dynamic process referred to as “carriage” [2]. Mucosal carriage is a necessary prerequisite for
meningococcal disease. Carriage of N. meningitidis causes disease when it breaches the host
epithelial barriers and invades the bloodstream or penetrates the subarachnoidal cavity and
infects the meninges [3].
N. meningitidis are classified into 12 serogroups (A, B, C, E, H, I, K, L, W, X, Y and Z),
based on the structure and chemical composition of their capsular polysaccharide [4]. The ser-
ogroups associated with disease in the African meningitis belt are A, W, X, Y and C. With ser-
ogroup A epidemics being eliminated following the introduction of the serogroup A conjugate
vaccine MenAfriVac[5–7], non-A meningococcal serogroups become the major cause of
meningococcal disease in sub Sahelian Africa. Recently, large serogroup C epidemics occurred
in Niger and Nigeria, [8] demonstrating the epidemic potential of non- serogroup A meningo-
cocci. Timely control and prevention of the epidemics have been a challenge due to vaccine
shortages, which has resulted in tremendous pressure on hospital facilities and public health
authorities. Serogroup B, a common cause of meningococcal disease in many high-income
countries [9], is rarely detected in the meningitis belt. Serogroups E, I, H, K, L, Z are less com-
monly identified in invasive disease. Queries on the more than 38,633 records on PubMLST.
org/neisseria website have demonstrated that serogroups E and Z are found both in invasive
and carriage specimens, serogroups K, L, H are only found in carriage samples but very rarely,
and serogroup I was not found at the time of writing. Furthermore, previous carriage studies
in Europe have identified a high proportion of N. meningitidis isolates, among which, up to
30–45% did not express their capsule genes [10] and 16–20% lacked regions A, B and C of the
capsular polysaccharide synthesis (cps) genes, known as a capsule null (cnl) genotype [11].
Several meningococcal cross-sectional carriage studies have been conducted in the African
meningitis belt in recent years, including surveys in Burkina Faso [12, 13], and in seven other
countries (Chad, Ethiopia, Ghana, Mali, Niger, Nigeria and Senegal) as part of the MenAfriCar
project [14, 15]. Conventional microbiological methods have been used in these studies to
detect and characterise meningococci, but these methods are time consuming, expensive and
susceptible to errors. Consequently, many African laboratories have been increasingly adopt-
ing molecular biology tools to detect and characterise N. meningitidis and its capsular geno-
types as they are more sensitive, specific, and less time consuming than bacteriological
methods. DNA-based methods such as Polymerase Chain Reaction (PCR) have greatly
improved laboratory diagnosis [16]; many studies have developed reliable PCR assays for the
detection of N. meningitidis [17–19] and characterization of its capsular genogroup using spe-
cific genes. However, most studies have focused on the common disease serogroups, A, B, C,
W, X and Y [20–23]. Fewer studies have investigated PCR for the detection of cnl or ser-
ogroups E, H, and Z which are mostly found in carriage [20, 24]. Some research groups have
developed gel-based PCR assays for the detection and genogrouping of N. meningitidis
whereas others have used real-time quantitative PCR (qPCR) protocols. The choice of one
technique over another is often dictated by budgetary considerations, as qPCR is more expen-
sive but less subject to contamination. Evaluation of the impact of meningococcal conjugate
vaccines requires sensitive and specific PCR assays that cover all serogroups to accurately and
thoroughly assess the epidemiology of N. meningitidis carriage and disease, including the
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potential emergence of less common groups through strain replacement and/or capsule
switching [25].
The present study was conducted within the MenAfriCar project, which collected pharyn-
geal swabs from over 60,000 subjects in seven countries within the African meningitis belt
[15]. Our objectives were to improve N. meningitidis carriage assessment by developing and
optimising a simple, accurate and standardised multiplex PCR algorithm for the detection of
N. meningitidis species and its capsular genogroups including: (i) the most prevalent gen-
ogroups A, B, C, X, Y and W (ii) carriage-associated genogroups such as E, H, and Z; and (iii)
unencapsulated capsule null meningococci. Both traditional gel-based PCR and qPCR that can
be adapted to African laboratories were validated using carriage isolates collected as part of
MenAfriCar studies.
Material and methods
Literature search for available primers/probes
A literature search was undertaken to identify PCR methods with primers and probes pub-
lished on N. meningitidis detection and characterization. The NCBI PubMed database was
used with search terms “Neisseria meningitidis” and “PCR” (date of access: November 2011).
The different techniques and detection algorithms were evaluated in order to define the most
appropriate ones for our context. A focus was placed on summarising the best gel-based and
qPCR assays already existing for detection and characterization of meningococci.
In silico specificity screen—Evaluation of selected primers and probes
A total of 112 primers and 16 probes reported in the literature were chosen for further analysis.
Firstly, nucleotide mismatches were identified through the comparison with consensus
sequences derived from target genes obtained from the pubMLST.org/neisseria website
(accessed on September 2012). Primer and probe sequences were compared to all available
allelic variants of the target genes to determine whether they were conserved in the majority of
alleles available at that time. Technical checks on all primers and probes were then undertaken
using the Primer Express software design guidelines (Applied Biosystem International (ABI),
Villon sur Yvette, France): melting point temperatures (Tm) and potential secondary struc-
tures were assessed with optimal Tm varying between 58–60˚C and 68–70˚C for primers and
probes respectively. Finally, nucleotide BLAST searches were undertaken using the NCBI
BLAST tool to identify possible cross-reactions with other bacteria [26]. Primers and probes
with more than 3 base pair (bp) differences compared to the consensus sequences were not
used. Secondary structures or self-dimers were minimised, to avoid their potential detrimental
effect on the efficiency of the reaction, but their presence was not a systematic criterion for
rejection. Sequences were retained if they displayed 100% coverage according to the NCBI
BLAST tool. When the result of these evaluations was unsatisfactory, new primers and/or
probes were created.
Positive controls
Positive controls consisted of purified DNA from genogroups: A (isolate name: Z2491); W
(A22); X (860060); Y (71/94); B (EG329, BZ198); C (L93/4286); Z (0084/93); E (297–0); H (H/
ASH/87); and capsule null (0083/93) [27] as well as two genogroup E isolates (M07746,
M22445). Reference strains for genogroups A and X, were purchased from the American Type
Culture Collection (ATCC). Another confirmed capsule null isolate from the first Malian
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MenAfriCar cross-sectional study (sample 01-010664-XS1) (18) was used as a cnl positive
control.
Carriage isolates
N. meningitidis isolates were collected during the first MenAfriCar cross-sectional studies as
previously described [15]. Briefly, pharyngeal swabs were obtained from participants in the
rural and urban sites of six centres in Chad, Ethiopia, Ghana, Mali, Niger and Senegal. Sus-
pected N. meningitidis were subjected to oxidase test, Gram stain, biochemical tests and sero-
agglutination [28]. Boiled cell suspensions to release high concentration of DNA were pre-
pared in each center as part of the MenAfriCar routine protocol from bacteria grown over-
night on blood agar plates [15]. Extracted DNA samples from all oxidase positive bacteria were
also sent to the University of Oxford [14] for molecular characterization. A subset of character-
ized samples was chosen to constitute a representative panel of the most prevalent N. meningi-
tidis genogroups as well as non N. meningitidis from each country. Next, the selected boiled
cell suspension extracted DNA samples were sent to the Center for Vaccine Development in
Mali (CVD-Mali) where PCR validation was conducted. A total of 247 extracted DNA samples
were received, with 42, 38, 18, 46, 44 and 59 samples from Chad, Ethiopia, Ghana, Niger, Mali
and Senegal, respectively.
Characterisation of N. meningitidis at the University of Oxford, UK
Neisseria species were analysed using the rplF assay [29]. All samples were also tested with a
capsule null (cnl) sequencing assay [11] or sequencing of a fragment of the ctrA gene allowing
the characterisation of genogroup A, E, K, L, X and Z. Samples that were positive for N. menin-
gitidis and negative for cnl were tested by a qPCR multiplex assay to determine genogroups A,
B, C, W, X and Y [23]. These results were considered as the reference or gold standard for this
study since the assays described above were already validated and published.
Novel gel-based PCR assay design and optimization in Bamako, Mali
New primers were designed for sodC, genogroup Z, and H using the online tools Primer 3 and
Primer quest (Table 1)[30, 31]. A ready-to-load Master Mix (rlMMx) from Solis Biodyne, sta-
ble at room temperature and therefore very convenient for transport and testing in Africa, was
employed. rlMMx with different concentrations of MgCl2 were tested to find the optimal con-
centration for the assay. Thermal cycling conditions were the same for all tests: 1 cycle of 3
minutes (min) at 95˚C; 35 cycles of 30 seconds (s) at 95˚C; 30 s at 55˚C; 30 s at 72˚C. This was
followed by 1 cycle of 10 min at 72˚C and a final conservation step at 4˚C.
Novel quantitative real-time PCR (qPCR) assay design and optimization in
Bamako, Mali
Although our assay was developed to determine whether a specimen is positive or negative for
meningococci and their genogroups, we keep the term “qPCR” to comply with the MIQE
guidelines [32]. Quantification of meningococci would not add any information in our context
since we were working with DNA samples extracted from bacterial culture. Primers and
probes were designed for the N. meningitidis species-specific gene porA and for the non-spe-
cies-specific cnl, and a modified species-specific sodC probe was designed based on a previ-
ously published method [18]. Genogroups were determined using the 2nd (A, W, X) and 3rd
(B, C, Y) qPCR multiplexes developed by Wang et al. [23]. Primers and probes for these gen-
ogroups were kindly provided by the Centers for Disease Control and Prevention (CDC).
Detection and characterization of Neisseria meningitidis by PCR in Africa
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Primers and probes were also designed for genogroups E, H, and Z using the Primer Express
software from ABI. Minor Groove Binding (MGB) hydrolysis probes were designed, as
opposed to Black Hole Quencher (BHQ) hydrolysis probes which are more difficult to manu-
facture. The sodC probe was modified in Primer Express to make it 12 base pairs shorter and
accommodate an MGB quencher (Table 2). All primers/probe were tested at the following
concentrations in a 25 μl solution: 900nM/250nM; 600nM/200nM; 300nM/100nM and
100nM/50nM respectively. Optimal concentrations in a TaqMan Gene Expression MasterMix
(reference: 4369016 from ABI) were identified for each primers/probe set and used subse-
quently in the different assays. Cycling conditions were similar for all tests: 1 cycle of 2 min at
50˚C, 1 cycle of 10 min at 95˚C followed by 50 cycles of 15 s at 95˚C and 1 min at 60˚C. The
ABI 7500 fast cycler was used to perform the reaction and the results analysed using the 7500
Fast software (see dx.doi.org/10.17504/protocols.io.rjsd4ne for detailed information).
Study design and statistical analyses
Initially, 16 positive controls, representing all target genogroups (A, B, C, W, X, Y, H, E, Z,
cnl), were used for the optimization of both gel-based and qPCR in monoplex and appropri-
ate multiplexes. Optimal qualitative results from monoplex and multiplex assays were evalu-
ated for gel-based PCR by visualizing the quality and strength of the bands, whereas optimal
Table 1. Primer sequences for gel-based PCR.
Gene Primer name Sequence Start/end Size Reference
porA porA 2F GCG GTT TTG CCG GGA ACT AT 755–1017 251 Bennett, DE, 2006
porA 15R AGT GGC GGC AAT TTC GGT CGT ACT
galE-cnl-tex GH26R (cnl aF) GGT CGT CTG AAA GCT TGC CTT GCT C 250–226 432 Claus, H, 2002
HC344 (cnl aR) GGA TTG GAC GAG CGA GAC 72–55
sodC sodC-F2 GCG GTT AGT GCA GTA TGT TCA G 113–641 530 Present study
sodC-R2 TAA TCA CGC CAC ATG CCA TA
mynB/csaB 98–28 (AF) CGC AAT AGG TGT ATA TAT TCT TCC 270–664 395 Taha, MK, 2000
98–29 (AR) CGT AAT AGT TTC GTA TGC CTT CTT
siaD (csw) 98–32 (W135F) CAG AAA GTG AGG GAT TTC CAT A 911–1030 120 Taha, MK, 2000
98–33 (W135R) CAC AAC CAT TTT CAT TAT AGT TAC TGT
Xcba (csxA) X-10 (F) ACA GCC CAT AAA ACA CCC GTA TCA TC 142–343 202 Yaro, S, 2012
X-11 (R) GTG ATT GGA ATC TTC CAA TAT CGG T
siaD (csb) 98–20 (BF) GCA TGC TGG AGG AAT AAG CAT TAA 645–1099 455 Taha, MK, 2000
98–19 (BR) GGA TCA TTT CAG TGT TTT CCA CCA
siaD (csc) 98–17 (CF) TCA AAT GAG TTT GCG AAT AGA AGG T 789–1054 266 Taha, MK, 2000
98–18 (CR) CAA TCA CGA TTT GCC CAA TTG AC
siaD (csy) 98–34 (YF) CTC AAA GCG AAG GCT TTG GTT A 911–1030 120 Taha, MK, 2000
98–35 (YR) CTG AAG CGT TTT CAT TAT AAT TGC TAA
cshC cshC-F1 GTG CCG ATA TTG CCT CAG AT 2378–2533 156 Present study
cshC-R1 CTT CGG ATG GGA ACT TGA AA
cap29EH 39429 (29E aF) TTG GCG GTT GAA ACC TTA C 22–715 694 Zhu, H, 2011
39430 (29E aR) GCG TAT CAT GCT CCA TTA CCA
cszC cszC-Fwd (ZF) AGG TTC ATC TGC TGG GAT TAC GCT 3506–3806 301 Present study
cszC-Rev (ZR) AAG CGA TTA ATG GCC TGT TGC TGG
Sequences, positions and amplicons size of each primer pair used in the 4 multiplexes. In bold are base pairs that showed a mismatch with at least one of the alleles
present in pubMLST, but not with the majority of them.
https://doi.org/10.1371/journal.pone.0206453.t001
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conditions were defined for the qPCR assay using quantitative Ct values. Then, 44 Malian
isolates were analysed using all primers and probes in monoplex and multiplex assays in
parallel to further evaluate the optimized PCR conditions for multiplex assays and ensure
the multiplex assays were comparable to monoplex assays. Later, as more samples were pro-
spectively characterized at Oxford University from other MenAfriCar countries, samples
from Chad, Ethiopia, Ghana, Niger and Senegal were tested with the optimized multiplex
assays (Fig 1). Sensitivity, specificity, positive predictive value (PPV) and negative predictive
value (NPV) (see definitions in Table 3) were calculated for primers/probe triplets (forward
Table 2. Primer and probe sequences for qPCR.
Gene Primer/Probe name Sequence Start/end Concentration (nM) Reference
porA porA_fwd_1 GCC GGC GTT GAT TAT GAT TT 1126–1145 600 Present study
porA_rev_1 AGT TGC CGA TGC CGG TAT T 1210–1192 600
porA_Pb_1 FAM (MGB) CTT CCG CCA TCG TGT C 1157–1172 200
sodC Nm sodC FWd 351 GCA CAC TTA GGT GAT TTA CCT GCA T 446–470 600 Dolan, T,
2011Nm sodC Rev 478 CCA CCC GTG TGG ATC ATA ATA GA 551–573 600
sodC Pb387 NED (MGB) CAT GAT GGC ACA GCA A 482–497 100 Present study
galE/cnl/tex cnl_fwd_2 GAA TTG CAT AGG TTA TCC AAA ATC AC 110–85 900 Present study
cnl_fwd_2b GAG TTG CAC AGA TTA TCC AGA ATC AC 110–85 900
cnl_rev_4 TTT GCC CGA TAC AAT CTG AAA G 85–106 900
cnl_Pb_2 VIC (MGB) ATA AAA CCG GTG CCG CC 38–22 250
csw/synG F857 TAT TTA TGG AAG GCA TGG TGT ATG 935–958 600 Wang, X, 2011
R964 TTG CCA TTC CAG AAA TAT CAC C 1063–1042 600
Pb907i FAM (BHQ) AAA TAT GGA GCG AAT GAT TAC AGT AAC TAT AAT GAA 985–1020 200
csaB/sacB F2531 AAA ATT CAA TGG GTA TAT CAC GAA GA 934–959 900 Mothershed, EA, 2004
R2624 ATA TGG TGC AAG CTG GTT TCA ATA G 1025–1001 900
Pb2591i HEX (BHQ) CTA AAA GTA GGA AGG GCA CTT TGT GGC ATA AT 992–961 250
csxB/xcbB F173 TGT CCC CAA CCG TTT ATT GG 429–448 900 Mothershed, EA, 2004
R237 TGC TGC TAT CAT AGC CGC C 493–475 900
Pb196 CY5 (BHQ) TGT TTG CCC ACA TGA ATG GCG G 452–473 250
csb/synD F737 GCT ACC CCA TTT CAG ATG ATT TGT 737–760 900 Wang, X, 2011
R882 ACC AGC CGA GGG TTT ATT TCT AC 905–883 900
Pb839i CY5 (BHQ) AAG AGA TGG GYA ACA ACT ATG TAA TGT CTT TAT TT 839–873 250
csc/synE F478 CCC TGA GTA TGC GAA AAA AAT T 591–612 600 Mothershed, EA, 2004
R551 TGC TAA TCC CGC CTG AAT G 664–646 600
Pb495i FAM (BHQ) TTT CAA TGC TAA TGA ATA CCA CCG TTT TTT TGC 612–644 200
csy/synF F787 TCC GAG CAG GAA ATT TAT GAG AAT AC 865–890 900 Wang, X, 2011
R929 TTG CTA AAA TCA TTC GCT CCA TAT 1010–987 900
Pb1099i HEX (BHQ) TAT GGT GTA CGA TAT CCC TAT CCT TGC CTA TAA T 948–981 250
cseE/cap29eF cseE-2_Fwd1 GAGGCTGGCAATGACCAATT 470–488 600 Present study
cseE-2_Rev1 CCCAGCATATCGACAACCAA 548–529 600
cseE-2_Pb1 FAM (MGB) ATCTTATGTGAACGTGGCGC 490–509 200
cszC/capZD cszC-1_Fwd1 CAG GCC GAA GAG CGT TAT CA 895–914 900 Present study
cszC-1_Rev1 CGC CAT TCA GGG CGA TT 950–934 900
cszC-1_Pb1 NED (MGB) ACA GCT CTG GCC TTA G 916–931 250
cshC cshC-1_Fwd1 AAG CCC GTT CCA AGA TCA TG 1491–1510 600 Present study
cshC-1_Rev1 GCG GTT TGG AGA AAT AAT ATG TGT T 1563–1539 600
cshC-1_Pb1 VIC (MGB) AAT GTC AGC CGT AAC TT 1513–1529 200
Sequences, positions and concentrations of primers and probes used in the 4 multiplexes, MGB: Minor Groove Binding/ BHQ: Black Whole Quencher, are two different
types of Quencher. The probes obtained from CDC had a BHQ while the ones designed for this study the MGB quencher. In bold are base pairs that showed a mismatch
with at least one of the alleles present in pubMLST, but not with the majority of them.
https://doi.org/10.1371/journal.pone.0206453.t002
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primer, reverse primer and probe for each qPCR) using the results obtained from Oxford
University as a gold standard.
Results
Literature search and evaluation of primers and probes
Eleven papers describing 112 primers and 16 probes for gel-based or qPCR methods to detect
and characterize meningococci were identified (S1 Table). Only papers that described the
primer and probe sequences were used. Gel-based PCR assays targeting different genes were
identified for N. meningitidis detection: 1 assay for crgA, 2 for porA, 2 for ctrA and 1 for sodC.
Similarly, qPCR assays for characterization of genogroups were analyzed: 3 for A, 3 for W, 7
for X, 5 for B, 4 for C, 3 for Y, 1 for H, 2 for E, and 1 for Z.
Fig 1. Summary of the methodology employed in the study and samples tested.
https://doi.org/10.1371/journal.pone.0206453.g001
Table 3. Definition of sensitivity, specificity, positive predictive value and negative predictive value.
Carriage of meningococci (confirmed by the gold standard in Oxford):
PCR outcome/carriage Carriage present No carriage
Positive True Positive (TP) False Positive (FP)
Negative False Negative (FN) True Negative (TN)
Sensitivity (SS): Proportion of samples positive by the gold standard technique (true carriers) that were positive by
PCR. Sensitivity = TP/(TP+FN)
Specificity (SP): Proportion of samples negative by the gold standard technique (true non-carriers) that were negative
by PCR. Specificity = TN/(TN+FP)
Positive Predictive Value (PPV): Probability to have a positive result with the new PCR when it is positive with the
gold standard (carriage of meningococci or carriage of the tested strain). PPV = TP/(TP+FP)
Negative Predictive Value (NPV): Probability to have a negative result with the new PCR when it is negative with the
gold standard (no meningococcal carriage or carriage of the tested strain). NPV = TN/(TN+FN)
https://doi.org/10.1371/journal.pone.0206453.t003
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For the gel-based PCR assays: the same primers were often chosen for detection and geno-
grouping in different papers. The most frequent were for characterization of genogroups A,
W, Y, B, C [22], and X [33]. For the qPCR assays: primers/probe triplets (forward primer,
reverse primer and probe) were retrieved for porA (1 triplet), ctrA (2 triplets), and sodC (1 trip-
let) for the detection of N. meningitidis and for genogroups A (1 triplet), W (2 triplets), X (1
triplet), B (3 triplets), C (3 triplets), Y (2 triplets). In one of the most recent comprehensive
assays, two multiplex PCR for genogroups A, W, X and B, C, Y were used successively [23].
Nineteen (14 primers and 5 probes–see Tables 1 and 2) out of the 68 primers and probes
sequences evaluated within the PubMLST database had 1 to 3 mismatches, compared with the
consensus sequences, which was considered acceptable. The Tm and dimer analyses generally
gave acceptable results for gel-based and qPCR, except for H and Z that had to be redesigned
to fit the cycling conditions in the gel-based PCR assay (Tables A, B, C, D, E, F, G and H in S2
Table). A final list of 47 primers and 12 probes was evaluated for our detection and characteri-
zation of the PCR algorithm (Tables 1 and 2). Primers and probes regions are represented
schematically on their respective loci in Panels A, B, C and D in S1 Fig.
Optimisation of the four multiplex assays (1- porA, sodC, cnl; 2- A, W, X;
3- Y, B, C; 4- H, E, Z)
Sixteen positive controls from different genogroups were used to optimize both the gel-based
and the real-time PCR assays.
For gel-based assay, the optimal MgCl2 concentration for the assay was determined to be
10.4mM and this concentration was retained for the remaining experiments. Each reaction
consisted of a 30μl solution with 0.5μl of each primer, 4μl of rlMMx (monoplex) or 6μl of
rlMMx (multiplex) and molecular biology grade water (ddH2O).
Table 2 presents the optimal concentrations for the selected primers and probes for real-
time PCR (qPCR). The qPCR reaction consisted of a 25μl solution with 12.5 μl of 2X Gene
Expression Master Mix and ddH2O.
Evaluation of sensitivity, specificity, PPV and NPV compared with our gold standard
(S3 Table).
Gel-based assay (Table A in S3 Table):
Sixteen positive controls and the samples from Mali (n = 44) were used to compare mono-
plex and multiplex PCR. All meningococci identified at the University of Oxford were cor-
rectly detected and characterized by monoplex gel-based PCR resulting in a sensitivity of 100%
for all genes except 75% for genogroup Y (see S3 Table). The porA and sodC sensitivities were
decreased to 82.14% and 96.43% respectively when working in multiplex whereas it was 100%
for cnl and all genogroups. The specificity of porA assay increased from 77.78% in monoplex
to 88.89% in multiplex, whereas specificity of sodC decreased from 29.64% in monoplex to
25.93% in multiplex. Specificity was 100% for cnl and all genogroups except X and Z with
96.55% and 96.30% respectively in monoplex and 100% for cnl and all genogroups except X
and B with 96.55% and 96.15% respectively in multiplex (Supplemental Table 3).
Real-time PCR assay (Table B in S3 Table):
Starting with 100ng of DNA, eight 2-fold serial dilutions were performed to determine the
Ct limit for categorizing a sample as positive. The last dilution, at a concentration of 0.79ng,
systematically had a Ct lower or equal to 30. This is roughly equivalent to 40,000 genome cop-
ies which is far lower than the expected number of colony forming units after culture. The Ct
limit was determined to be 30 cycles for crude DNA isolates. For this assay, a sample with a Ct
lower or equal to 30 was considered positive and samples above 30 were considered negative
(Fig 2).
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The sensitivity was 100% for all PCR assays evaluated in this study both in monoplex and
multiplex. Specificity was poor for sodC with 25.93% in monoplex and 29.63% in multiplex.
Specificity for porA was slightly decreased from 81.48% to 74.07% in multiplex. All cnl and
genogroups had a specificity of 100% both in monoplex and multiplex except genogroup X
with 96.55% in monoplex. No statistical differences were observed between the new MGB
sodC probe and the original BHQ sodC probe; however, the new MGB probe detected N.
meningitidis at lower Ct values (data not shown) and was included in the final assay.
Evaluation of the optimized multiplex assay using the pool of African
carriage isolates (Table 4)
The best performing assay was tested in multiplex on 203 isolates from five other countries of
the MenAfriCar study with the gel-based and qPCR assays making a total of 247 samples.
Again, the comparison was made with the gold standard results from Oxford: for the detection
by gel-based PCR assay, the best sensitivity was obtained with sodC (80.92%—with a specificity
of 69.47%) and the best specificity with porA (93.68% with a sensitivity of 70.39%). Sensitivity
for cnl and all genogroups ranged from 66.67% (genogroup X) to 100% for genogroup B and
E, whereas specificity ranged from 97.99% (genogroup X) and 100% (genogroups C, Y, H and
Z).
For the qPCR assay, the best sensitivity and specificity was obtained with porA (96.05% and
91.58% respectively) showing no advantage of using sodC (94.74% and 77.89% respectively).
For cnl and all genogroups, sensitivity ranged between 90% (genogroup A and Y) and 100%,
whereas specificity ranged between 99.33% (genogroup X) and 100% (Table 4).
The benefit of evaluating results from sodC and porA together, instead of individually from
the same multiplex, was analysed by comparing each primers/probe sets taken individually or
together. Sensitivity and NPV were improved by using both genes together and considering
Fig 2. qPCR standard curves. Eight two-fold dilutions of DNA from each positive control were performed and tested
in a qPCR assay with appropriate primers and probes. The Ct observed for each dilution is plotted against the DNA
concentration demonstrating a decrease in Ct with increased DNA concentration and detection for all genogroups
with a threshold of 30. sodC was empirically tested later and demonstrated the same threshold (data not shown).
https://doi.org/10.1371/journal.pone.0206453.g002
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positive any samples that were positive for at least one of the targets for the gel-based PCR
assay in comparison with porA or sodC alone from the same multiplex whereas the specificity
and PPV were decreased. For the qPCR assay all statistical results for sodC were lower or equal
to those for porA. Inclusion of sodC did not provide additional value (Table 4).
From the panel of 247 samples from all six different countries, 152 were characterized
as N. meningitidis at the University of Oxford using rplF sequencing [29]. Of these,
88.82% (135) isolates were correctly identified as meningococci by the gel-based PCR
assay and 96.05% (146) by the qPCR assay. All genogroups, but H and Z, were identified
in the panel tested: the most commonly represented was the cnl with 43.9%/48.4% (gel
based/qPCR). Some genogroups considered as rare in the region were detected, such as B
(2%) and E (0.66%) by both assays.
Table 4. Statistical analysis results for the multiplex gel-based and qPCR assays.
Gel-based
multiplex
SS SS 95% CI SP SP 95% CI PPV PPV 95% CI NPV NPV 95% CI
porA 70.4 62.4, 77.5 93.7 86.8, 97.6 94.7 88.8, 98.0 66.4 57.8, 74.3
sodC 80.9 73.7, 86.8 69.5 59.2, 78.5 80.9 73.8, 86.8 69.5 59.2, 78.5
Cnl 85.5 75.6, 92.5 98.7 92.9, 100 98.5 91.8, 100 87.2 78.3, 93.4
A 75.0 50.9, 91.3 99.2 95.9, 100 93.8 69.8, 99.8 96.3 91.6, 98.8
W 81.5 61.9, 93.7 98.4 94.3. 99.8 91.7 73.0, 99.0 96.1 91.1, 98.7
X 66.7 9.4, 99.1 98.0 94.2, 99.6 40.0 5.3, 85.3 99.3 96.3, 100
B 100.0 29.2, 100 99.3 96.3, 100 75.0 19.4, 99.4 100.0 97.5, 100
C 80.0 28.3, 99.5 100.0 97.5, 100 100.0 39.8, 100 99.3 96.3, 100
Y 80.0 44.4, 97.5 100.0 97.4, 100 100.0 63.1, 100 98.6 95.1, 99.8
H NA NA 100.0 97.6, 100 NA NA 100.0 97.6, 100
E 100.0 2.5, 100 99.3 96.3, 100 50.0 1.3, 98.7 100.0 97.6, 100
Z NA NA 100.0 97.6, 100 NA NA 100.0 97.6, 100
porA/sodC 88.8 82.7, 93.3 67.4 57.0, 76.6 81.3 74.6, 86.9 79.0 68.5, 87.3
Real-time
multiplex
SS SS 95% CI SP SP 95% CI PPV PPV 95% CI NPV NPV 95% CI
porA 96.1 91.6, 98.5 91.6 84.1, 96.3 94.8 90.0, 97.7 93.5 86.5, 97.6
sodC 94.7 89.9, 97.7 77.9 68.2, 85.8 87.3 81.2, 91.9 90.2 81.7, 95.7
Cnl 94.7 87.1, 98.5 100.0 95.3, 100 100.0 95.0, 100 95.0 87.7, 98.6
A 90.0 68.3, 98.8 100.0 97.2, 100 100.0 81.5, 100 98.5 94.7, 99.8
W 92.6 75.7, 99.1 100.0 97.1, 100 100.0 86.3, 100 98.4 94.4, 99.8
X 100.0 29.2, 100 99.3 96.3, 100 75.0 19.4, 99.4 100.0 97.5, 100
B 100.0 29.2, 100 100.0 97.5, 100 100.0 29.2, 100 100.0 97.6, 100
C 100.0 47.8, 100 100.0 97.5, 100 100.0 47.8, 100 100.0 97.5, 100
Y 90.0 55.5, 99.7 100.0 97.4, 100 100.0 66.4, 100 99.3 96.2, 100
H NA NA 100.0 97.6, 100 NA NA 100.0 97.6, 100
E 100.0 2.5, 100 99.3 96.4, 100 50.0 1.3, 98.7 100.0 97.6, 100
Z NA NA 100.0 97.6, 100 NA NA 100.0 97.6, 100
porA/sodC 96.1 91.6, 98.5 77.9 68.2, 85.8 87.4 81.4, 92.0 92.5 84.4, 97.2
Results of both PCR assays tested only in multiplex on a panel of 247 samples from Chad, Ethiopia, Ghana, Mali, Niger and Senegal. Sensitivity, Specificity, PPV and
NPV were assessed for each primers pair and primers/probe in the multiplex assays and presented as percentages (%) with 95% confidence intervals (CI).
https://doi.org/10.1371/journal.pone.0206453.t004
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Discussion
Conventional bacteriological methods that are usually routinely used to detect and character-
ize meningococci are complex, long and involve several overnight cultures and chemical tests
which might generate error [15]. Developing a simple and rapid PCR algorithm that detects
and characterizes carriage of meningococci is important, especially in the meningitis belt
where recent vaccinations with conjugate vaccines were carried out and carriage is usually low
[14]. Therefore, it is important to correctly detect N. meningitidis in a context where transmis-
sion is high especially in young children and where the period of carriage is short [34].
In this study, after an in silico evaluation of the existing primers and probes, we evaluated a
multiplex PCR algorithm by comparison with techniques that were validated and published in
a reference laboratory at the University of Oxford (24, 30). Our multiplex PCR algorithm was
later used for a meningococcal carriage study in The Gambia and improved the detection of
carried meningococci by more than twice (239%) [35].To our knowledge, this is the first time
that such an extensive evaluation was made for a carriage study in the meningitis belt, using
the most advanced tools and following recommended advanced guidelines for qualitative tech-
niques [32].
To optimise the sensitivity of our algorithm for the detection of meningococci, we targeted
both porA and sodC genes simultaneously. The published sodC gel-based PCR primers were
re-designed due to too many mismatches against the consensus sequence [18]. Similarly, prim-
ers and probe of qPCR targeting porA available from the literature [17] yielded too many mis-
matches and were re-designed entirely. Designing qPCR primers and probes for cnl
identification was not an easy task as the cnl sequence is short and variable, but the design of
two complementary forward primers (Table 2), allowed the complete coverage of the cnl
sequences that were present in pubMLST at that time. Recent comparison of primers/probes
sequences used in this study with a larger number of sequences now available in the pubMLST
identified additional point mutations in newly published alleles (data not shown). Although
most alleles are still covered by the primers and probes developed here, new variations within
these primers/probes sequences may lead to decreased sensitivity and we advise a complete
new in silico evaluation of primers and probes before using these. Since pubMLST is exponen-
tially growing, we recommend our methodology to be applied–or, at a minimum, blasting of
primers and probes to make them more robust–when developing or implementing new
molecular diagnosis tools for N. meningitidis as well as other pathogens. The variability of the
targeted genes between meningococcal strains might explain the sensitivity and specificity var-
iations observed between monoplex and multiplex assays and future studies will be needed to
investigate this further for the detection of N. meningitidis.
A major strength of the developed algorithm is that the first multiplex assay (porA, sodC
and cnl) allows the simultaneous detection of meningococci and the presence/absence of their
capsule locus. Since cnl genotype is most common among meningococcal strains in carriage
[11, 14], this assay improves the rapidity of N. meningitidis characterization. The sequential
use of the following three multiplex assays for genogroup characterization, from the most fre-
quent groups (A, W, and X followed by B, C, and Y) to the carriage uncommon genogroups
(E, H and Z) in the meningitis belt, further reduces the time required for meningococcal char-
acterization. The primers/probe sequences used for these genogroup assays could also be mod-
ified to fit the variable epidemiology of meningococci by region and over time.
In this study, we have developed an algorithm that: (i) has a high sensitivity for the detec-
tion of meningococci; and, (ii) allows rapid characterization of all genogroups with high speci-
ficity. A strength of gel-based assays is that the assays joined two commonly used genes to
detect N. meningitidis: porA and sodC in multiplex, which improved the sensitivity from
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70.39% for porA and 80.92% for sodC alone to 88.82% (see Table 4) for meningococcal detec-
tion. However, no improvement in sensitivity and specificity was observed when adding sodC
in the multiplex qPCR assay and we advise using only porA/cnl for the qPCR. This might be
due to the modification of the published sodC probe to accommodate a MGB quencher in
order to harmonize the quenchers in the first multiplex (porA, sodC, cnl). Indeed, “BHQ”
probes are difficult to obtain from oligonucleotide suppliers, because of their unusual design
[23]. A subsequent comparison of 44 Malian samples tested with both BHQ and MGB probes
showed no differences in detection of isolates. However, the efficacy of the shortened MGB
sodC probe should be further investigated.
For genogroup characterization, multiplex qPCR that has already been evaluated were vali-
dated in gel-based PCR platform. The statistical results varied from one genogroup to the
other (Table 4). For the two multiplexes (A, W, and X; B, C, and Y), published primers/probes
were used and their statistical results were acceptable for all genogroups. The genogroup X
primers set had the lowest sensitivity and PPV in the gel-based assay and may require redesign.
Overall, the qPCR assay yielded better results than the gel-based PCR and should be the pre-
ferred assay for genogroup characterization.
Our study used the laboratory results obtained from Oxford University as reference stan-
dard for the statistical analysis. The sensitivity, specificity, PPV and NPV may be affected by
the transport conditions when DNA samples were shipped from MenAfriCar countries and
how the samples were processed at Oxford University. This may have affected our compari-
sons between PCR tests realized in Bamako and analyses in Oxford. In addition, no qPCR
assay for the rare genogroups H, E, and Z was available in Oxford, making the direct compari-
son difficult. The results generated in this study were compared to the ctrA sequencing results
when available and may explain some of the observed discrepancies; indeed, the comparison
of two different techniques could explain the low PPV for group E in both assays.
The quality of the template may have also affected the detection of meningococci as most
studies use DNA purified by kits. Boiled cell suspensions were purposely used to make our
assays as inexpensive as possible and the good statistics obtained with those crude samples
demonstrate the efficacy of the assays. Stringent rules were applied to determine whether a test
was positive or not: by qPCR, a CT threshold of 30 was chosen based on preliminary results
obtained (Fig 2), whereas the CDC/WHO reference guidelines recommend a threshold of 35
which, with the reagents and conditions used in our study, would have led to a considerable
number of false positives.
In conclusion, this algorithm allows the detection of N. meningitidis with high sensitivity
for samples from 6 different countries of the meningitis belt, it significantly reduces the num-
ber of tests required for meningococcal detection and allows very specific characterization of
samples for carriage studies in comparison with conventional bacteriological techniques.
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